UK Public Sector Contracts & Tenders

HealthTrust Europe is establishing an Open Framework Agreement to appoint suppliers capable of providing a full range of Goods and Services, including: Managed Service Solutions, Dental Consumables, Orthodontic Materials, Dental Implants, Biologics and Facial Aesthetics, Practice Management Software, Dental Equipment and Pathway Solutions, and Mobile or Modular Dental Health Units. It is intended the framework will be divided into the following lots: Lot 1 Dental Solutions Managed Service incorporating a suite of goods and services: Dental Consumables Dental Equipment (inclusive of any ongoing Repairs, Maintenance and Total Asset Management) Dental Patient Management Software Solutions Clinical Dental Technicians and Workforce Digital Dental Technologies Dental Practice TurnKey / refurbishment Solutions Dental Mobile/Modular Health Units Lot 2 - Dental Consumables Lot 3 - Orthodontic Materials Lot 4 – Dental Implants, Biologics and Facial Aesthetics Lot 5 – Practice Management Software Solutions Lot 6- Dental Equipment and pathway solutions Lot 7 - Mobile and modular units The bodies to whom the use of this framework will be open include all contracting authorities in the United Kingdom as defined in Section 1 of the Procurement Act 2023. In particular, the entities in the UK (especially those of a health and/or social care nature) listed in the downloadable spreadsheet at the following link are envisaged as framework users: https://www.ons.gov.uk/methodology/classificationsandstandards/economicstatisticsclassifications/introductiontoeconomicstatisticsclassifications This list includes each organisation’s successors and assigns, any equivalent organisations, and associated organisations created due to any organisational changes. This framework will be open to: Any bodies or organisations operating in the UK of a health and/or social care nature; Any organisations with similar procurement needs; Any UK-based central government authority listed in Annex I of Directive 2014/24/EU, to the extent still relevant under retained EU law and consistent with the Procurement Act 2023.

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.